Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Inflammatory Cytokine Services In Usa
4 services found
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Studies have shown that Acute Respiratory Distress Syndrome (ARDS) following viral pneumonia is one of the most common causes of death from COVID-19[1],[2],[3],[4],[5]. A cytokine storm (CS) refers to excessive and uncontrolled release of pro-inflammatory cytokines that commonly present as systemic inflammation, multiple organ failure, and high ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Eicosanoid, including prostaglandin (PG), thromboxane (TX), leukotriene (LT), and lipoxin (LX), is critical signaling molecule. Prostanoid, a subset of eicosanoids, comprises PG and TX. Prostanoids are named based on the number of carbon-carbon double bonds in their molecules. Most biologically active PGs and TXs belong to the series 2 molecules with two carbon-carbon double bonds. ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Testing Services to Support Your Preclinical and Phase I-IV Drug Programs. Nexelis, a Q² Solutions Company, provides biomarker assay services in inflammation and immunology, oncology, organ injury (renal), nutritional health, cardiovascular, metabolic (NASH/NAFLD) and infectious diseases. Our scientists approach your projects with flexible and creative solutions, developing fit-for-purpose ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Systemic lupus erythematosus (SLE) is a classic systemic autoimmune disorder characterized by impaired autoimmune tolerance and high concentration of autoantibodies targeting self-antigens, which lead to organ damage. This pathological process involves multiple cytokines. ...